i2c has built a wealth of knowledge in the area of respiratory drug formulation, device development and research. Its three principal scientists collectively have more than 75 years of R&D experience in this field.

Bespoke R&D laboratories for inhaled product & device development and to support clinical trials:

• pMDI , DPI & Nebuliser Evaluation, Research & Development
• Aerosol particle sizing and inhaler performance characterisation
• Dose uniformity and potency tests
• Moisture content
• Analytical methods development and optimisation
• Technology transfer: staff training/knowledge transfer
• pMDI production using one and two stage filling
• DPI small scale powder blending
• Accelerated stability testing

What We Do

Formulation: Characterisation
& Development

Small Scale Manufacture
& Testing

Clinical Gamma